X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemotherapy (7) 7
index medicus (7) 7
breast cancer (6) 6
female (6) 6
humans (6) 6
oncology (6) 6
adult (5) 5
aged (5) 5
cancer (5) 5
middle aged (5) 5
aged, 80 and over (4) 4
disease-free survival (4) 4
male (4) 4
survival (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
cancer therapies (3) 3
care and treatment (3) 3
clinical trials (3) 3
epidermal growth factor (3) 3
open-label (3) 3
pathological complete response (3) 3
patients (3) 3
treatment outcome (3) 3
adjuvant treatment (2) 2
breast neoplasms - drug therapy (2) 2
breast neoplasms - metabolism (2) 2
breast neoplasms - mortality (2) 2
cancer patients (2) 2
clinical medicine (2) 2
combination (2) 2
confidence intervals (2) 2
erlotinib (2) 2
erlotinib hydrochloride (2) 2
gene expression (2) 2
growth factors (2) 2
hematology (2) 2
hematology, oncology and palliative medicine (2) 2
her2 (2) 2
kaplan-meier estimate (2) 2
medical prognosis (2) 2
multicenter (2) 2
multivariate analysis (2) 2
mutation (2) 2
neoadjuvant (2) 2
neoadjuvant therapy (2) 2
neoplasms. tumors. oncology. including cancer and carcinogens (2) 2
phase-ii trial (2) 2
phase-iii trial (2) 2
preoperative chemotherapy (2) 2
proportional hazards models (2) 2
receptor, erbb-2 - metabolism (2) 2
retrospective studies (2) 2
review (2) 2
risk factors (2) 2
studies (2) 2
surgical adjuvant breast (2) 2
therapy (2) 2
trastuzumab (2) 2
tumors (2) 2
women (2) 2
womens health (2) 2
1st-line treatment (1) 1
30-minute infusion (1) 1
abemaciclib (1) 1
absorption spectroscopy (1) 1
adenocarcinoma (1) 1
adipose tissues (1) 1
adjuvant (1) 1
adolescent (1) 1
advanced breast cancer, hormonal therapy (1) 1
aedes-albopictus (1) 1
algorithms (1) 1
alpha (1) 1
alphavirus infections - complications (1) 1
alphavirus infections - epidemiology (1) 1
amenorrhea (1) 1
amino acids (1) 1
analysis (1) 1
androgen receptor expression (1) 1
androgens (1) 1
anthracyclines (1) 1
anthracyclines - administration & dosage (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antigens (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
arctic medicine. tropical medicine (1) 1
arthritis (1) 1
axillary lymph-node (1) 1
binding (1) 1
biophysics (1) 1
bmi (1) 1
body composition (1) 1
body mass index (1) 1
brain (1) 1
brca (1) 1
breast - metabolism (1) 1
breast - pathology (1) 1
breast cancer; dual targeting; her2; lapatinib; neoadjuvant; pertuzumab; trastuzumab; trastuzumab-emtansine; hematology; oncology; geriatrics and gerontology (1) 1
breast neoplasms - chemistry (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 10, pp. 981 - 988
Journal Article
Breast cancer targets and therapy, ISSN 1179-1314, 2018, Volume 10, pp. 39 - 49
Endocrine treatment represents the cornerstone of endocrine-sensitive premenopausal early breast cancer. The estrogen blockade plays a leading role in the... 
Amenorrhea | LHRH | Adjuvant | Hormone therapy | Complications and side effects | Gonadotropin releasing hormone | Young women | Dosage and administration | Breast cancer | Drug therapy | Health aspects | Risk factors | Estrogen | Oncology | Patients | Cancer therapies | Studies | Signal transduction | Chemotherapy | Womens health | Fertility | Pituitary gland | Clinical medicine | Prostate | hormone therapy | amenorrhea | adjuvant
Journal Article
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 7/2013, Volume 139, Issue 7, pp. 1229 - 1240
... • Antonino Grassadonia • Giancarlo Bisagni • Nicola Tinari • Andrea Michelotti • Germano Zampa • Stefania Gori • Luca Moscetti • Michele De Tursi • Michele Panebianco... 
Medicine & Public Health | Hematology | Pathological complete response | Oncology | Cancer Research | Internal Medicine | Neoadjuvant | Breast cancer | HER2 | Survival | Trastuzumab | SURGICAL ADJUVANT BREAST | INDUCTION CHEMOTHERAPY | COMPLETE REMISSION | AXILLARY LYMPH-NODE | STAGE-II | PHASE-II TRIAL | PREOPERATIVE CHEMOTHERAPY | ONCOLOGY | SYSTEMIC TREATMENT | INTERNATIONAL EXPERT PANEL | Neoplasms, Hormone-Dependent - metabolism | Multivariate Analysis | Neoplasms, Hormone-Dependent - mortality | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Carcinoma, Ductal, Breast - mortality | Breast Neoplasms - metabolism | Carcinoma, Ductal, Breast - drug therapy | Anthracyclines - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Adult | Female | Neoadjuvant Therapy | Retrospective Studies | Chemotherapy, Adjuvant | Carcinoma, Ductal, Breast - metabolism | Gene Expression | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | Aged | Neoplasms, Hormone-Dependent - drug therapy | Anthracyclines | Chemotherapy | Analysis | Cancer | Original Paper
Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 07/2013, Volume 19, Issue 28, pp. 4511 - 4519
Journal Article
Journal of cellular physiology, ISSN 1097-4652, 2018, Volume 234, Issue 6, pp. 7708 - 7717
Journal Article
Cancer, ISSN 0008-543X, 01/2007, Volume 109, Issue 2, pp. 274 - 281
BACKGROUND. For patients with stage IV nonsmall cell lung cancer (NSCLC) who present with brain metastasis (BMs), standard platinum‐based chemotherapy regimens... 
whole‐brain radiotherapy | brain | metastasis | chemotherapy | nonsmall cell lung cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.